Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Cognetivity Neurosciences CEO Sina Habibi Interviewed on BBC World News

C.CGN

Canada NewsWire

VANCOUVER, May 22, 2018 /CNW/ - Cognetivity Neurosciences Ltd. (the "Company" or "Cognetivity") (CSE: CGN) (FWB:1UB) today announced that its CEO, Sina Habibi, took part in a live interview for BBC's World News broadcast in London, England on Monday May 14th.

The interview was conducted as part of the BBC's 'Inside Track' segment in which select leaders from innovative global companies are invited to discuss their Company's technology, business model and market potential.

The interview was aired live in the UK as well as on BBC World News, the corporation's commercially funded international news channel which broadcasts to over 200 countries worldwide. BBC World News is said to have the largest audience of any BBC channel, with an estimated 99 million viewers weekly in 2015/16, part of the estimated 265 million users of the BBC's four main international news services.

The interview can be viewed in full on Cognetivity's website at https://www.cognetivity.com/news/.

About Cognetivity Neurosciences Ltd.

Cognetivity is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical and commercial environments. Cognetivity's ICA uses Artificial Intelligence and machine learning techniques to help detect the earliest signs of impairment by testing the performance of large areas of the brain, potentially allowing early diagnosis of dementia. Cognetivity aims to develop the ICA through planned clinical studies to the market in North America and Europe.

For more information, please visit: www.cognetivity.com

ON BEHALF OF THE BOARD

 "Sina Habibi"                                               

Sina Habibi
Chief Executive Officer and Director

FORWARD LOOKING STATEMENTS:

The forward-looking information contained in this press release is made as of the date of this press release and, except as required by applicable law, the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking information, whether as a result of new information, future events or otherwise, except as may be required by law. By its very nature, such forward-looking information requires the Company to make assumptions that may not materialize or that may not be accurate. This forward-looking information is subject to known and unknown risks and uncertainties and other factors, which may cause actual results, levels of activity and achievements to differ materially from those expressed or implied by such information.

The Exchange does not accept responsibility for the adequacy or accuracy of this release.

SOURCE Cognetivity Neurosciences Ltd

View original content: http://www.newswire.ca/en/releases/archive/May2018/22/c8318.html

Tags:


Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today